Resumen
Objective: There are impressive differences in the incidence, prevalence and experience of women and men with Alzheimer’s Disease (AD). Notably, two-thirds of those with AD, the most common form of dementia, are women. Our objective was to provide a literature-based framework to understand these sex and gender differences in AD. Methods: We conducted a narrative review to examine sex and gender influences on AD. Results: We present a framework to understanding why these sex and gender differences exist in AD. This includes the influence of longevity (women live longer than men), biological differences (hormonal differences, epigenetics and frailty), differences in cognitive performance (women and men tend to perform differently on some cognitive tests), and gendered social roles and opportunities (educational and occupational opportunities, functional roles post-retirement). Our review clearly indicates the complex interaction of these sex and gender differences and variability within each. Conclusions: Given these important sex and gender differences in AD, we provide recommendations and steps forward describing how both sex and gender should be considered in dementia diagnosis and management and in the design and implementation of dementia research, including studies of caregiving interventions and models of dementia care.
Idioma original | English |
---|---|
Publicación | Women's Health |
Volumen | 14 |
DOI | |
Estado | Published - 2018 |
Nota bibliográfica
Funding Information:This work came about as a result of the authors’ affiliation with the Canadian Consortium on Neurodegeneration in Aging (CCNA). MKA leads CCNA Team 14 on Multimorbidity in relation to dementia; MCT leads the CCNA’s Women, Sex, Gender and Dementia cross-cutting program. The CCNA receives funding from the Canadian Institutes of Health Research (CNA-137794) and partner organizations ( www.ccna-ccnv.ca ). M.C.T. is supported by a Clinician Scientist Award from the Department of Family & Community Medicine, University of Toronto and from Sunnybrook Health Sciences Center, Toronto, ON.
Funding Information:
This work came about as a result of the authors? affiliation with the Canadian Consortium on Neurodegeneration in Aging (CCNA). MKA leads CCNA Team 14 on Multimorbidity in relation to dementia; MCT leads the CCNA?s Women, Sex, Gender and Dementia cross-cutting program. The CCNA receives funding from the Canadian Institutes of Health Research (CNA-137794) and partner organizations (www.ccna-ccnv.ca). M.C.T. is supported by a Clinician Scientist Award from the Department of Family & Community Medicine, University of Toronto and from Sunnybrook Health Sciences Center, Toronto, ON. The author(s) received no financial support for the research, authorship, and/or publication of this article.
Publisher Copyright:
© The Author(s) 2018.
ASJC Scopus Subject Areas
- General Medicine